Israeli biotechnology company’s cannabis and mushroom combination kills 90% of deadly cells in colon cancer patients

Israeli biotechnology company’s cannabis and mushroom combination kills 90% of deadly cells in colon cancer patients
https://cannabisnewsbox.com/feed/

A brand new research effort carried out by Cannabotech indicates that the Herzliya, Israel-based company’s selection of Integrative-Colon products could be a powerful treatment option for colon cancer.  In fact, researchers affiliated with the biotechnology company claimed that 90 percent of colon cancer cells were obliterated in a cell model study after being treated with the company’s oncological products. Composed of natural mushroom and cannabis extracts, Cannabotech’s products present colon cancer patients with promise for the future and could one day be adopted as treatment of choice. Cannabotech’s Integrative Colon products performed well on various colon cancer subtype The Israeli team assessed the efficacy of their Integrative Colon products on a broad scope of colon cancer subtypes. Each case of colon cancer features a range of molecular changes that commonly occur in patients with the disease.  In order to glean their findings, the team assessed product composition against the activity of each cannabinoid one-by-one. As per the results, the structure of the Integrative Colon products proved to be more effective than each cannabinoid separately, thus demonstrating a forceful synergistic effect between the functioning ingredients.  What’s more, the study discovered that each cannabinoid produced different effects on each colon cancer subtype. These findings support Cannabotech’s claims that a science-based formula must be developed in order to accomplish a suitable treatment option for colon cancer. Cannabotech’s mushroom extract-containing products are enriched with a high potency of PSK, which is derived from the Trametes mushroom — a type of mushroom that grows in many countries across the world. PSK has been acknowledged in studies for its anti-cancer capabilities. It has even been given the go-ahead for use in Taiwan, Japan, and South Korea as an oncology treatment. Cannabotech hopes to assess formula efficacy in combination with standard chemotherapies With their findings, the Israeli…

Excerpt only …
READ MORE BELOW
Source : Israeli biotechnology company’s cannabis and mushroom combination kills 90% of deadly cells in colon cancer patients

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.